Patent · US Active

Crystalline pharmaceutical

US8796451B2 · kind B2 · utility

0Cited by
4References
17Claims
0Family size

Assignee

Inventors

Key dates

Filing dateMay 13, 2011
Grant dateAug 5, 2014
Priority date—
Expiry dateJun 19, 2032

Classification

  • Technology area (CPC A)Human Necessities
  • CPC primaryA61P31/18
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

New crystalline forms of lopinavir are disclosed.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.